| # | Title | Journal | Year | Citations |
|---|
| 1 | Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up | Breast Cancer Research and Treatment | 2019 | 265 |
| 2 | Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease | PLoS ONE | 2011 | 140 |
| 3 | Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer | Clinical Cancer Research | 2020 | 120 |
| 4 | A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers | Cancer Chemotherapy and Pharmacology | 2016 | 46 |
| 5 | LBA25 Final overall survival (OS) analysis from ARCHES: A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) + androgen deprivation therapy (ADT) in men with metastatic hormone-sensitive prostate cancer (mHSPC) | Annals of Oncology | 2021 | 25 |
| 6 | Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2 | Clinical Breast Cancer | 2020 | 21 |
| 7 | Clinical and Statistical Assessment of Suicidal Ideation and Behavior in Pharmaceutical Trials | Clinical Pharmacology and Therapeutics | 2011 | 19 |
| 8 | Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice | International Journal of Clinical Practice | 2013 | 19 |
| 9 | Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel‐Group, Randomized, Placebo‐controlled Clinical Trials | Pain Practice | 2017 | 19 |
| 10 | The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women | Journal of Human Lactation | 2016 | 17 |
| 11 | The burden of caring for dementia patients: caregiver reports from a cross-sectional hospital-based study in China | Expert Review of Pharmacoeconomics and Outcomes Research | 2013 | 15 |
| 12 | Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial | Clinical Cancer Research | 2022 | 11 |
| 13 | A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects | Clinical Pharmacology in Drug Development | 2020 | 7 |
| 14 | Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study | Intestinal Research | 2020 | 7 |
| 15 | Serum β-nerve growth factor concentrations in pregnant female, nonpregnant female, and male cynomolgus monkeys | NeuroReport | 2014 | 5 |
| 16 | The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants | Clinical Pharmacokinetics | 2021 | 5 |
| 17 | Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single‐Dose, Matched Case‐Control Study | Clinical Pharmacology in Drug Development | 2021 | 4 |
| 18 | Efficacy and safety of palbociclib plus endocrine therapy in women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the Asia-Pacific region: Data from PALOMA-2 and -3 | Annals of Oncology | 2017 | 2 |
| 19 | Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers | Cancer Chemotherapy and Pharmacology | 2021 | 2 |
| 20 | ARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of high and low disease volume and risk groups | Annals of Oncology | 2019 | 0 |
| 21 | 635P ARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of efficacy by baseline prostate-specific antigen (PSA) levels | Annals of Oncology | 2020 | 0 |
